Skip to main content

Lobbying activity

Who's lobbying Congress, for whom, and on what, from federal Lobbying Disclosure Act filings. Covers both chambers, synced daily. 1,397 filings

Top spenders & firms Spend by issue

Clear
Q2
BURRELL INTERNATIONAL GROUP LLC for TONIX PHARMACEUTICALS HOLDING CORP.
2nd Quarter (Apr 1 - June 30) 2025 · New Jersey · House · Senate · $40,000.00 income
Pharmacy
View →
Q2
BURRELL INTERNATIONAL GROUP LLC for SHIONOGI INC.
2nd Quarter (Apr 1 - June 30) 2025 · New Jersey · House · Senate · $30,000.00 income
Pharmacy
View →
RR
DLA PIPER LLP (US) for CALIFORNIA APARTMENT ASSOCIATION
2nd Quarter (Apr 1 - June 30) 2025 · California
Pharmacy
View →
Q2
CAPITOL COUNSEL LLC for PCCA, INC.
2nd Quarter (Apr 1 - June 30) 2025 · Texas · House · Senate · $60,000.00 income
Pharmacy
View →
Q2
KYOWA KIRIN, INC for KYOWA KIRIN, INC
2nd Quarter (Apr 1 - June 30) 2025 · New Jersey · House · Senate
Pharmacy, Trade (domestic/foreign)
View →
Q2
CASSIDY & ASSOCIATES, INC. for HIMS & HERS HEALTH, INC.
2nd Quarter (Apr 1 - June 30) 2025 · California · House · Senate · $60,000.00 income
Health Issues, Pharmacy
View →
Q2
BCBSM, INC. for BCBSM INC
2nd Quarter (Apr 1 - June 30) 2025 · Minnesota · House · Senate
Health Issues, Budget/Appropriations, Pharmacy
View →
Q2
KAISER FOUNDATION HEALTH PLAN INC. for KAISER FOUNDATION HEALTH PLAN INC
2nd Quarter (Apr 1 - June 30) 2025 · California · House · Senate
Health Issues, Medicare/Medicaid, Taxation/Internal Revenue Code, Defense
View →
Q2
ICE MILLER LLP for COALITION FOR RESPONSIBLE COMPOUDING INC.
2nd Quarter (Apr 1 - June 30) 2025 · Texas
Pharmacy
View →
Q2
BROWNSTEIN HYATT FARBER SCHRECK, LLP for ELI LILLY AND COMPANY, FORMERLY REPORTED AS, LILLY USA, LLC
2nd Quarter (Apr 1 - June 30) 2025 · Indiana · Senate · $90,000.00 income
Pharmacy, Health Issues
View →
Q2
VENN STRATEGIES for THE PERSONAL CARE PRODUCTS COUNCIL
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate · $40,000.00 income
Health Issues, Pharmacy
View →
Q2
S-3 GROUP for GOODRX
2nd Quarter (Apr 1 - June 30) 2025 · California · House · Senate · $20,000.00 income
Pharmacy, Health Issues
View →
Q2
W STRATEGIES, LLC for PHLOW CORP.
2nd Quarter (Apr 1 - June 30) 2025 · Virginia · House · Senate · $50,000.00 income
Pharmacy
View →
Q2
BLUE CROSS BLUE SHIELD OF MICHIGAN for BLUE CROSS BLUE SHIELD OF MICHIGAN
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate
Health Issues, Medicare/Medicaid, Pharmacy
View →
Q2
UC HEALTH for UC HEALTH
2nd Quarter (Apr 1 - June 30) 2025 · Ohio · House · Senate
Medicare/Medicaid, Defense, Pharmacy
View →
Q2
VAN SCOYOC ASSOCIATES for NATIONAL ASSOCIATION OF CHAIN DRUG STORES
2nd Quarter (Apr 1 - June 30) 2025 · Virginia · House · Senate · $60,000.00 income
Health Issues, Medicare/Medicaid, Pharmacy
View →
Q2
DA VINCI GROUP for PROCARE, INC.
2nd Quarter (Apr 1 - June 30) 2025 · Georgia · House · Senate · $20,000.00 income
Pharmacy
View →
Q2
DLA PIPER LLP (US) for NOVARTIS
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate · $40,000.00 income
Pharmacy, Medical/Disease Research/Clinical Labs, Copyright/Patent/Trademark, Taxation/Internal Revenue Code
View →
Q2
THE MICHAEL J. FOX FOUNDATION FOR PARKINSON'S RESEARCH for THE MICHAEL J. FOX FOUNDATION FOR PARKINSON'S RESEARCH
2nd Quarter (Apr 1 - June 30) 2025 · New York · House · Senate
Medicare/Medicaid, Agriculture, Taxation/Internal Revenue Code, Health Issues
View →
Q2
VAN SCOYOC ASSOCIATES for ZEBRA TECHNOLOGIES CORP.
2nd Quarter (Apr 1 - June 30) 2025 · New Jersey · Senate · $30,000.00 income
Consumer Issues/Safety/Products, Pharmacy
View →
Q2
AEGIS LLC for TRIS PHARMA, INC.
2nd Quarter (Apr 1 - June 30) 2025 · New Jersey · House · Senate · $50,000.00 income
Pharmacy
View →
Q2
AEGIS LLC for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate · $60,000.00 income
Pharmacy, Health Issues
View →
Q2
BROWNSTEIN HYATT FARBER SCHRECK, LLP for WALGREEN CO.
2nd Quarter (Apr 1 - June 30) 2025 · Illinois · Senate · $50,000.00 income
Pharmacy
View →
Q2
TRAVERE THERAPEUTICS for TRAVERE THERAPEUTICS
2nd Quarter (Apr 1 - June 30) 2025 · California · House · Senate
Health Issues, Pharmacy, Medical/Disease Research/Clinical Labs, Medicare/Medicaid
View →
Q2
POLARIS GOVERNMENT RELATIONS, LLC for CIGNA CORPORATION
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate · $90,000.00 income
Health Issues, Pharmacy
View →
Previous Page 39 of 56 Next

Source: federal Lobbying Disclosure Act filings. A filing's bill references are parsed from its activity descriptions, so a bill page shows the filings that named it.

Report a problem